USPTO serial 85243484
INTERNATIONAL GENOMICS CONSORTIUM
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 6, 2011
- Examiner
- MCMORROW, JANICE LEE
- Law office
- GENERIC WEB UPDATE
What this means
Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection. Calendar the next Section 8 and 9 deadline in 10 years and maintain monitoring.
Need help with INTERNATIONAL GENOMICS CONSORTIUM?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
The International Genomics Consortium
Phoenix, AZ
Other trademarks owned by The International Genomics Consortium
The International Genomics Consortium
Phoenix, AZ
Other trademarks owned by The International Genomics Consortium
The International Genomics Consortium
Phoenix, AZ
Other trademarks owned by The International Genomics Consortium
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
HOWARD I. SOBELMAN
HOWARD I. SOBELMAN Snell & Wilmer LLPOne East Washington StreetSuite 2700Phoenix, AZ 85004Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | medical research support services, namely, recruitment of patients and subjects for various studies | ACTIVE | Sep 30, 2003 |
| 039 | Distributing clinical specimens, such as blood and tissue samples, to research entities for correlative studies | ACTIVE | Sep 30, 2003 |
| 042 | Research and scientific analysis, namely, molecular and genomic sequencing and analysis comprising genomic research, bioinformatics, and diagnostic technologies to analyze complex genetic diseases; collection, processing and storage of blood and tissue samples and associated genomic data and clinical outcome information, and utilizing standardized protocols linked to a centralized molecular profiling laboratory to perform such analysis. Establishing and augmenting national and international standards for consent, tissue collection, clinical annotation, molecular analysis and representation of data; providing online medical and research information relating to biological samples obtained under standardized conditions, along with associated gene expression data and long-term patient clinical outcome data to accelerate the discovery of targets for therapy, prognosis and diagnosis; providing a research platform to allow users to facilitate transitioning of genomic discoveries from the bench to a patient's bedside to improve patient care; pharmaceutical drug development services, medical and scientific research consultation services in the field of clinical trials; medical research, collecting and analyzing clinical samples, analyzing clinical data, and DNA sequencing all in the fields of genomics, biomedicine, biosciences, and bioinformatics; computer software development services in the fields of genomics, biomedicine, biosciences, and bioinformatics | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by The International Genomics Consortium
- Other trademarks owned by The International Genomics Consortium
- Other trademarks owned by The International Genomics Consortium
- Other trademarks in Class 035
- Other trademarks in Class 039
- Other trademarks in Class 042
- Similar marks named INTERNATIONAL GENOMICS CONSORTIUM
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 4, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Nov 4, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 4, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 17, 2021 | NA89 | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | — |
| Mar 17, 2021 | RNL1 | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active. |
| Mar 17, 2021 | 89AG | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | The USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary. |
| Mar 17, 2021 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Dec 7, 2020 | E89R | TEAS SECTION 8 & 9 RECEIVED | — |
| Dec 6, 2020 | REM2 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | — |
| Dec 23, 2017 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Dec 23, 2017 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Dec 23, 2017 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Nov 30, 2017 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Dec 6, 2011 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 20, 2011 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 31, 2011 | NPUB | NOTICE OF PUBLICATION | — |
| Aug 17, 2011 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Aug 16, 2011 | ALIE | ASSIGNED TO LIE | — |
| Aug 3, 2011 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 3, 2011 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Aug 2, 2011 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Aug 2, 2011 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jul 13, 2011 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 12, 2011 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 12, 2011 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 27, 2011 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 27, 2011 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 18, 2011 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 22, 2011 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 19, 2011 | NWAP | NEW APPLICATION ENTERED | — |